Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Sanofi Consumer Healthcare India Ltd (SANOFICONR) is currently trading at 4,742.80 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Sanofi Consumer Healthcare India Limited focuses on the consumer healthcare segment after being demerged from Sanofi India Limited. The demerger was implemented as part of a Scheme of Arrangement, effective from June 1, 2024, marking a new phase for the company. 23,030,622 equity shares were issued to shareholders of Sanofi India Limited as part of the demerger process. The company's focus will likely involve leveraging its strong brand association with Sanofi to penetrate the consumer healthcare market effectively.
Over the past 52 weeks, Sanofi Consumer Healthcare India Ltd has traded between a low of ₹3,950.50 and a high of ₹5,493.10. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Sanofi Consumer Healthcare India Ltd has a market capitalization of approximately 10,773.38. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Sanofi Consumer Healthcare India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.77 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 10,773.38 Cr, Sanofi Consumer Healthcare India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Sanofi Consumer Healthcare India Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Sanofi Consumer Healthcare India Ltd is 41.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
8
Neutral
2
Bullish
4
Bearish
8
Neutral
2
Bullish
36
Bearish
0
Neutral
0
Bullish
32
Sanofi Consumer Healthcare India Limited focuses on the consumer healthcare segment after being demerged from Sanofi India Limited.
The demerger was implemented as part of a Scheme of Arrangement, effective from June 1, 2024, marking a new phase for the company.
23,030,622 equity shares were issued to shareholders of Sanofi India Limited as part of the demerger process.
The company's focus will likely involve leveraging its strong brand association with Sanofi to penetrate the consumer healthcare market effectively.
Pharmaceuticals & Biotechnology
Pharmaceuticals
10,923 Cr
Low Risk
42.3
37.2
1.9
28.1
5,493.10
3,950.50
Sales CAGR
Profit CAGR
ROE
ROCE
Board Meeting
Sanofi Consumer Healthcare India Ltd informed exchanges that its Board will meet on 2026-07-28 to consider and approve unaudited financial results for the quarter and half year ended 30 June 2026. Trading window closed 2026-07-01 to 2026-07-30.
Board Meeting
Sanofi Consumer Healthcare India Ltd: Board to meet on 28 July 2026 to consider and approve unaudited financial results for the quarter and half year ended 30 June 2026; trading window closed 01 Jul–30 Jul 2026.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
259.85 | 11,352 Cr | 71.05 | 4.03 | 0.00 | 7.07 | 13.01 | 4.44 | ||
6780.50 | 11,257 Cr | 34.43 | 21.46 | 6.12 | 62.32 | 84.14 | 38.86 | ||
576.55 | 10,906 Cr | 44.01 | 5.05 | 0.19 | 18.22 | 24.16 | 15.10 | ||
4671.45 | 10,773 Cr | 41.77 | 28.05 | 1.60 | 62.53 | 75.60 | 47.15 | ||
676.00 | 10,638 Cr | 41.69 | 3.21 | 0.43 | 7.70 | 10.95 | 4.71 | ||
868.00 | 9,676 Cr | 55.96 | 10.95 | 0.00 | 19.57 | 22.16 | 14.83 | ||
1045.20 | 9,623 Cr | 17.30 | 3.10 | 0.48 | 17.90 | 17.30 | 8.29 | ||
| Median: 7 Co. | — | 868.00 | 10,773 Cr | 41.77 | 5.05 | 0.43 | 18.22 | 22.16 | 14.83 |
